Diabetes treatment does not increase risk of bone fracture

According to a recent study inOsteoporosis International, antidiabetic therapies, GLP-1 agonists, SGLT2 inhibitors and DPP-IV inhibitors, do not increase the risk of bone fractures in patients with type 2 diabetes.Healio
Source: Society for Endocrinology - Category: Endocrinology Source Type: news